Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-30 8:02 pm Sale |
2020-07-28 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
Armistice Capital, LLC | 0 0.000% |
-1,460,019 (Position Closed) |
Filing History |
| 2020-07-29 5:18 pm Purchase |
2020-07-28 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
7,263,236 100.000% |
6,178,236 (+569.42%) |
Filing History |
| 2020-06-30 5:37 pm Unchanged |
2020-06-29 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
1,085,000 14.900% |
0 (Unchanged) |
Filing History |
| 2020-06-30 4:37 pm Unchanged |
2020-06-24 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
Armistice Capital, LLC | 1,460,019 19.990% |
0 (Unchanged) |
Filing History |
| 2020-06-25 9:58 pm Unchanged |
2020-06-24 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
1,085,000 14.900% |
0 (Unchanged) |
Filing History |
| 2020-06-22 5:17 pm Purchase |
2020-06-15 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
LA JOLLA PHARMACEUTICAL CO LJPC |
1,085,000 14.900% |
1,085,000 (New Position) |
Filing History |
| 2020-06-11 4:38 pm Purchase |
2020-06-04 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH |
Armistice Capital, LLC | 1,460,019 19.990% |
40,512 (+2.85%) |
Filing History |